Tesamorelin

Tesamorelin – GHRH Analog Research Peptide

Tesamorelin is a synthetic Growth Hormone‑Releasing Hormone (GHRH) analog supplied as a laboratory reagent for endocrinological and biochemical research. In controlled in‑vitro studies, this peptide has been examined for its activation of GHRH receptors and the downstream signaling cascades associated with growth hormone (GH) release from pituitary cell models.

Tesamorelin is referenced in research on metabolic regulation, lipolysis, and muscle‑related signaling pathways. The reagent is manufactured under stringent laboratory conditions and verified by High‑Performance Liquid Chromatography (HPLC) to a confirmed purity of ≥99%. Each batch is intended exclusively for controlled, in‑vitro research applications.

Key Specifications

• Name: Tesamorelin

• Molecular Formula: C221H366N72O67S

• Molecular Weight: ≈5,135.8 Da

• Form: Lyophilized Powder

• Purity: ≥99% (HPLC verified)

• Storage: Store refrigerated; protect from light and moisture

• Shelf life: Sealed lyophilizate. Shelf life 24 months from manufacture.

Research Applications

• Studied for its role in GHRH receptor activation and growth hormone signaling in in‑vitro endocrine models.

• Used as a reference reagent in research on metabolic signaling, lipolysis, and endocrine function.

• Applicable in endocrinological and biochemical in‑vitro assay development.

• Lyophilized format ensures stable, reproducible handling under standard laboratory conditions.

A batch‑specific Certificate of Analysis (CoA) is available on request and accompanies every order.